1 |
Hemler, M. E. (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu. Rev. Cell Dev. Biol. 19, 397-422.
DOI
ScienceOn
|
2 |
Hemler, M. E. (2005) Tetraspanin functions and associated microdomains. Nat. Rev. Mol. Cell Biol. 6, 801-811.
DOI
ScienceOn
|
3 |
Yanez-Mo, M., Barreiro, O., Gordon-Alonso, M., Sala-Valdes, M. and Sanchez-Madrid, F. (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends. Cell Biol. 19, 434-446.
DOI
ScienceOn
|
4 |
Lee, S. A., Lee, S. Y., Cho, I. H., Oh, M. A., Kang, E. S., Kim, Y. B., Seo, W. D., Choi, S., Nam, J. O., Tamamori-Adachi, M., Kitajima, S., Ye, S. K., Kim, S., Hwang, Y. J., Kim, I. S., Park, K. H. and Lee, J. W. (2008) Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma. J. Clin. Invest. 118, 1354-1366.
DOI
ScienceOn
|
5 |
Berditchevski, F. and Odintsova, E. (2007) Tetraspanins as regulators of protein trafficking. Traffic 8, 89-96.
DOI
ScienceOn
|
6 |
Charrin, S., le Naour, F., Silvie, O., Milhiet, P. E., Boucheix, C. and Rubinstein, E. (2009) Lateral organization of membrane proteins: tetraspanins spin their web. Biochem. J. 420, 133-154.
DOI
ScienceOn
|
7 |
Jung, O., Choi, S., Jang, S. B., Lee, S. A., Lim, S. T., Choi, Y. J., Kim, H. J., Kim, D. H., Kwak, T. K., Kim, H., Kang, M., Lee, M. S., Park, S. Y., Ryu, J., Jeong, D., Cheong, H. K., Park, K. H., Lee, B. J., Schlaepfer, D. D. and Lee, J. W. (2012) Tetraspan TM4SF5-dependent direct activation of FAK and metastatic potential of hepatocarcinoma cells. J. Cell Sci. 125, 5960-5973.
DOI
ScienceOn
|
8 |
Ghosh, A. K., Quaggin, S. E. and Vaughan, D. E. (2013) Molecular basis of organ fibrosis: potential therapeutic approaches. Exp. Biol. Med (Maywood). 238, 461-481.
DOI
ScienceOn
|
9 |
Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., De Franchis, R. and Colombo, M. (2004) Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126, 1005-1014.
DOI
ScienceOn
|
10 |
Severi, T., van Malenstein, H., Verslype, C. and van Pelt, J. F. (2010) Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta. Pharmacol. Sin. 31, 1409-1420.
DOI
|
11 |
Meindl-Beinker, N. M., Matsuzaki, K. and Dooley, S. (2012) TGF-beta signaling in onset and progression of hepatocellular carcinoma. Dig. Dis. 30, 514-523.
DOI
ScienceOn
|
12 |
Mantovani, A., Savino, B., Locati, M., Zammataro, L., Allavena, P. and Bonecchi, R. (2010) The chemokine system in cancer biology and therapy. Cytokine. Growth. Factor. Rev. 21, 27-39.
DOI
ScienceOn
|
13 |
Choi, S., Lee, S. A., Kwak, T. K., Kim, H. J., Lee, M. J., Ye, S. K., Kim, S. H., Kim, S. and Lee, J. W. (2009) Cooperation between integrin and tetraspan TM4SF5 regulates VEGF-mediated angiogenic activity. Blood 113, 1845-1855.
DOI
ScienceOn
|
14 |
Ryu, J., Kang, M., Lee, M. S., Kim, H. J., Nam, S. H., Song, H. E., Lee, D. and Lee, J. W. (2014) Cross-talk between the TM4SF5/FAK and the IL6/STAT3 pathways renders immune escape of human liver cancer cells. Mol. Cell Biol. 34, 2946-2960.
DOI
ScienceOn
|
15 |
Kang, M., Ryu, J., Lee, D., Lee, M. S., Kim, H. J., Nam, S. H., Song, H. E., Choi, J., Lee, G. H., Kim, T. Y., Lee, H., Kim, S. J., Ye, S. K., Kim, S. and Lee, J. W. (2014) Correlations between Transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities. PLoS ONE 9, e102817. doi: 10.1371/journal.pone.0102817.
DOI
ScienceOn
|
16 |
Lietha, D., Cai, X., Ceccarelli, D. F., Li, Y., Schaller, M. D. and Eck, M. J. (2007) Structural basis for the autoinhibition of focal adhesion kinase. Cell 129, 1177-1187.
DOI
ScienceOn
|
17 |
Lee, S. A., Kim, Y. M., Kwak, T. K., Kim, H. J., Kim, S., Kim, S. H., Park, K. H., Cho, M. and Lee, J. W. (2009) The extracellular loop 2 of TM4SF5 inhibits integrin on hepatocytes under collagen type I environment. Carcinogenesis 30, 1872-1879.
DOI
ScienceOn
|
18 |
Lee, S. A., Ryu, H. W., Kim, Y. M., Choi, S., Lee, M. J., Kwak, T. K., Kim, H. J., Cho, M., Park, K. H. and Lee, J. W. (2009) Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative. Hepatology 49, 1316-1325.
DOI
ScienceOn
|
19 |
Lee, M. S., Kim, H. P., Kim, T. Y. and Lee, J. W. (2012) Gefitinib resistance of cancer cells correlated with TM4SF5-mediated epithelial-mesenchymal transition. Biochim. Biophys. Acta. 1823, 514-523.
DOI
ScienceOn
|
20 |
Lee, S. Y., Kim, Y. T., Lee, M. S., Kim, Y. B., Chung, E., Kim, S. and Lee, J. W. (2006) Focal adhesion and actin organization by a cross-talk of TM4SF5 with integrin are regulated by serum treatment. Exp. Cell Res. 312, 2983-2999.
DOI
ScienceOn
|
21 |
Kang, M., Choi, S., Jeong, S. J., Lee, S. A., Kwak, T. K., Kim, H., Jung, O., Lee, M. S., Ko, Y., Ryu, J., Choi, Y. J., Jeong, D., Lee, H. J., Ye, S. K., Kim, S. H. and Lee, J. W. (2012) Cross-talk between TGFb1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition. Biochem. J. 443, 691-700.
DOI
ScienceOn
|
22 |
Kang, M., Jeong, S. J., Park, S. Y., Lee, H. J., Kim, H. J., Park, K. H., Ye, S. K., Kim, S. H. and Lee, J. W. (2012) Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in -treated mice. FEBS. J. 279, 625-635.
DOI
ScienceOn
|
23 |
Veenbergen, S. and van Spriel, A. B. (2011) Tetraspanins in the immune response against cancer. Immunol. Lett. 138, 129-136.
DOI
ScienceOn
|
24 |
Detchokul, S., Williams, E. D., Parker, M. W. and Frauman, A. G. (2013) Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies. Br. J. Pharmacol. doi: 10.1111/bph.12260.
DOI
ScienceOn
|
25 |
Lee, S. A., Park, K. H. and Lee, J. W. (2011) Modulation of signaling between TM4SF5 and integrins in tumor microenvironment. Front. Biosci. 16, 1752-1758.
DOI
|
26 |
Muller-Pillasch, F., Wallrapp, C., Lacher, U., Friess, H., Buchler, M., Adler, G. and Gress, T. M. (1998) Identification of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene 208, 25-30.
DOI
ScienceOn
|
27 |
Jung, O., Choi, Y. J., Kwak, T. K., Kang, M., Lee, M. S., Ryu, J., Kim, H. J. and Lee, J. W. (2013) The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation. Biochim. Biophys. Acta. 1833, 629-642.
DOI
ScienceOn
|
28 |
Choi, Y. J., Kim, H. H., Kim, J. G., Kim, H. J., Kang, M., Lee, M. S., Ryu, J., Song, H. E., Nam, S. H., Lee, D., Kim, K. W. and Lee, J. W. (2014) TM4SF5 suppression disturbs integrin -related signaling and muscle development in zebrafish. Biochem. J. 462, 89-101.
DOI
ScienceOn
|